Nuvalent Inc - Class A —— 财务报表 (NASDAQ:NUVL) | MetaTrader

展开完整图表

新闻

Nuvation Bio财报聚焦：Ibtrozi增长势头面临考验

Nuvation Bio earnings in focus: Ibtrozi momentum faces test

Does Nuvalent (NUVL) Have the Potential to Rally 37.26% as Wall Street Analysts Expect?

Nuvalent公布第四季度亏损,等待FDA对肺癌药物的决定

Nuvalent reports Q4 loss, awaits FDA decision on lung cancer drug

Drugmakers turn to AI to speed trials, regulatory submissions

Nuvalent Inc股票触及52周高点112.89美元

Nuvalent Inc stock hits 52-week high at 112.89 USD

FDA接受Nuvalent针对ROS1阳性非小细胞肺癌治疗的新药申请

FDA accepts Nuvalent’s NDA for ROS1-positive NSCLC treatment

Nuvalent (NUVL) chief legal officer Miller sells $676k in stock

Nuvalent CSO Pelish sells shares worth $501,752